‌$Proventi_老虎社区_美港股上老虎

boluo613
2022-11-18

‌$Provention Bio, Inc(PRVB)$ ‌TZIELD™ (teplizumab-mzwv) approved by FDA as the first and only treatment indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1D

由FDA批准的Tzield™（teplizumab-MZWV）是第一种也是唯一的治疗方法，该治疗方法延迟了8岁及8岁以上的成人和儿科患者的第3期1型糖尿病（T1D）的发作。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":667843701,"tweetId":"667843701","gmtCreate":1668726575903,"gmtModify":1668726577328,"author":{"id":3569806649777366,"authorId":3569806649777366,"authorIdStr":"3569806649777366","name":"boluo613","avatar":"https://static.tigerbbs.com/76878c45deee1566c2a4439d15dcd0b5","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>‌<a href=\"https://laohu8.com/S/PRVB\">$Provention Bio, Inc(PRVB)$ &nbsp;</a>‌TZIELD™ (teplizumab-mzwv) approved by FDA as the first and only treatment indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1D 由FDA批准的Tzield™（teplizumab-MZWV）是第一种也是唯一的治疗方法，该治疗方法延迟了8岁及8岁以上的成人和儿科患者的第3期1型糖尿病（T1D）的发作。</body></html>","htmlText":"<html><head></head><body>‌<a href=\"https://laohu8.com/S/PRVB\">$Provention Bio, Inc(PRVB)$ &nbsp;</a>‌TZIELD™ (teplizumab-mzwv) approved by FDA as the first and only treatment indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1D 由FDA批准的Tzield™（teplizumab-MZWV）是第一种也是唯一的治疗方法，该治疗方法延迟了8岁及8岁以上的成人和儿科患者的第3期1型糖尿病（T1D）的发作。</body></html>","text":"‌$Provention Bio, Inc(PRVB)$ ‌TZIELD™ (teplizumab-mzwv) approved by FDA as the first and only treatment indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1D 由FDA批准的Tzield™（teplizumab-MZWV）是第一种也是唯一的治疗方法，该治疗方法延迟了8岁及8岁以上的成人和儿科患者的第3期1型糖尿病（T1D）的发作。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/667843701","repostId":0,"isVote":1,"tweetType":1,"viewCount":5284,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PRVB"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":332,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}